Cresco Labs Inc. (CNSX:CL) entered into a definitive agreement to acquire Blair Wellness, LLC on August 17, 2021. The consideration will be satisfied through the payment of cash and a twenty-four (24) month promissory note. The Transaction will be completed on a cash-free, debt-free basis with a mutually agreed upon normalized target level of working capital.

The cash consideration would be payable upon closing of the Transaction. The Transaction implies a 1.8x 2021 revenue multiple. Blair Wellness team will join Cresco Family.

The closing of the Transaction is subject to, among other things, the approval and receipt of all required CSE and regulatory approvals. The Transaction is eexpected to close in Q4 of 2021. Acquisition is eexpected to be immediately accretive.